Fig. 5From: Distinct clinical features and prognostic factors of hepatitis C virus-associated non-Hodgkin’s lymphoma: a systematic review and meta-analysisMeta-analysis of the clinical outcomes between HCV-associated NHL patients receiving antiviral treatment and those not receiving antiviral treatment. a Overall survival (OS); b progression-free survival/disease-free survival (PFS/DFS); c overall response rate (ORR)Back to article page